No phaseRecruitingGeroscience intervention

ICOPE INTENSE-K Pilot Study

A ICOPE Intense Program Combined With Ketone Ester Pilot Study

Sponsor
University Hospital, Toulouse (Academic or other)
Enrollment
40 planned
Conditions
Ageing
Interventions
ICOPE intense intervention; Ketone Ester (KE) supplementation; Placebo; Vitamin D3; OMega 3; vitamin B9; Vitamin B12; Leucin-rich whey; ICOPE Step 1
Ages
older adults
Registry
NCT07048860

Full record on ClinicalTrials.gov

From the registry

ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.

Primary outcomes

  • Estimation of the effect size of the intervention on the cognitive function
  • Estimation of the effect size of the intervention on the muscle function
  • Estimation of the effect size of the intervention on the immune function

History

  1. Primary completion

  2. Last registry update

  3. Started

  4. Registered